Christine Ring (Chief Legal Officer) sold ~$134K of Nurix Therapeutics
Planned saleLoading…
NRIX · NASDAQ · Pharmaceutical Preparations
Pharmaceutical Preparations company based in Brisbane, Ca.
In the last 90 days, no insider of Nurix Therapeutics reported an open-market purchase and 1 open-market sale worth about $134K. Every figure links to its official SEC, House, Senate or USAspending record.
Last closeLast close, Oct 6, 2026
$22.60
Last 12 months
Not enough history
Market value
Not available
Bets against the stock: 18M shares sold short, +0.1% vs the previous count, 14.1 days of normal trading to buy them back. FINRA, as of Sep 15, 2026.
Revenue
$9.04M
−79.5% vs the same quarter a year earlier
Free cash flow, last 12 months
−$305M
This quarter −$98.5M, a year earlier −$65.8M
Net debt
—
Debt —, cash $67.7M, at May 31, 2026
Net income, last 12 months
−$341M
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Jul 9, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
1 sale
$134K sold. Insiders sell for many reasons.
New federal contracts, 12 months
None
Nothing found for this company
Christine Ring (Chief Legal Officer) sold ~$134K of Nurix Therapeutics
Planned saleChristine Ring (Officer) plans to sell ~$135K of Nurix Therapeutics
Planned, from payPrices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
1 active phase 3 trial and 2 active phase 2 trials led by this company, mostly in b-cell lymphoma, chronic lymphocytic leukemia (cll). The ones with the nearest registered primary completion date still ahead:
Source: ClinicalTrials.gov, studies whose lead sponsor is the company or a listed subsidiary. “Primary completion” is the sponsor's own registry date for the last main data collection. It is not an approval date, it says nothing about the result, and it is often revised.